[摘要] 目的 探究甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的临床疗效和安全性分析。方法 随机选取该院自2015年6月―2016年6月间收治的小儿难治性支原体肺炎患儿共100例作为研究对象，根据随机数表法分为对照组和观察组，每组各50例，其中对照组患儿进行常规接受阿奇霉素治疗，观察组患儿在对照组的常规治疗基础上联合甲泼尼龙治疗，连续治疗3个周期，观察并比较两组患儿的临床疗效以及不良反应。结果 经治疗后，可观察到观察组患儿的总有效率96.00%明?@高于对照组患儿的总有效率70.00%，差异具有统计学意义（P /6/view-10743243.htm
[关键词] 甲泼尼龙；阿奇霉素；小儿难治性支原体肺炎；临床疗效；安全性
[中图分类号] R725 [文献标识码] A [文章编号] 1674-0742（2017）09（b）-0120-03
[Abstract] Objective This paper tries to analyze the clinical effect of methylprednisolone and azithromycin in children with refractory mycoplasma pneumonia. Methods 100 children with refractory mycoplasma pneumonia treated from June 2015 to June 2016 in this hospital were random selected. The subjects were randomly divided into two groups， with 50 cases in each group. The control group took azithromycin treatment； the observation group took methylprednisolone and azithromycin treatment. After three treatment courses， the clinical effect and adverse reactions for two groups were observed. Results After treatment， the total effective rate for the observation group was 96.00%， significantly higher than the control group of 70.00%， and the difference was statistically significant （P
发表于 2018-8-15 11:59:58